A new biomarker to predict atrial fibrillation and its adverse events after coronary artery bypass surgery: red blood cell distribution volume.

Cardiovasc J Afr · 2023 · PMC11040473 · PMID 36637452

Europe PMC DOI

hedged sentence

0.0080

closest p · 0.2× alpha

0.0080

boldest claim

The sentences

highly significantp = 0.008actually significant

Mortality in the first postoperative month occurred in five patients (2.7%) in group 1 and in two patients (0.5%) in group 2, which showed a statistically highly significant difference between the groups (p = 0.008).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.